chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pruritic rash reported on 11/8/2010.  Reported for doctor visit on 11/23/2010. Received 80mg depomedrol and 40mg Kenalog IM.  Instructed to pick up OTC Claritin or Zyrtec and take daily.
After my second vaccine on 4/22/21, I woke up in the middle of the night with fever, chills and my RIGHT shoulder had a severe stabbing  pain that would not stop.  I also woke up to a UTI infection as well.  The fever and chills lasted for 24 hours and went away.  The right shoulder pain continued  for days.  By 4/29 the pain was too severe to tolerate.  At this point I could no longer move my arm at all and it was hot to touch and too painful to touch.   I went to the  ER 4/30 to see if they could help me with the pain.  They X-ray my shoulder, gave me a steroid shot to try to reduce the inflammation, a valium, toradol, and lidocaine patch for the pain.  They gave me the name of an orthopedic to see for a cortisone shot in my shoulder to reduce the inflammation.  I received about 15 hour relief from pain.  I saw Dr., orthopedic on Monday for my shoulder.  I gave her the timeline of  information.  She did an X-ray as well.  She gave me a cortisone shot in the back of the shoulder.  Within an hour I could immediately feel some relief.  By the next day I was able to move my arm some and not have the constant pain.  I have a follow up in 1 week.
Case number PHEH2014US022029 is an initial spontaneous report from the nurse received on 29 OCT 2014. This report refers to a 32-year-old female patient. She was vaccinated with FLUVIRIN 2014/2015 (batch number: 1411401) intramuscularly at a dose of 0.5 ml on 27 OCT 2014. On the same date, after vaccination she experienced redness and circle on the FLUVIRIN injection site and area was still red and hot to touch. The final outcome of the events was unknown. The seriousness and causality of the events were not reported.
Patient was given her first COVID vaccine on 2/1/21 and received Pfizer (EL3302). Upon returning for her second dose on 2/23/21 she did not bring her vaccine card and mistakenly told the vaccination site that her first dose was Moderna. The vaccine site did not confirm this and gave her a Moderna vaccination for her second shot. She had mild headache and neck pain after vaccination which resolved within 1 day. She does complain of intermittent nausea and neck stiffness since vaccination but states it is unknown if this is related to vaccination.
This spontaneous report a received from an unknown reporter, as a part of market research program refers to a unspecified number of patients of unknown age and gender enrolled in a project. No information about the patients medical history or concomitant medications was reported. The concurrent conditions of the patients included Human Immunodeficiency Virus infection (HIV). On an unknown date, the patients were vaccinated with PNEUMOVAX 23 (dose, lot #, expiry date and route of administration were not specified). The reporter stated, that there was still conflicting evidence about PNEUMOVAX 23 efficacy in Human Immunodeficiency Virus (HIV) patients though it was still recommended by most major organizations. The reporter indicated, that at least some adult patients received PREVNAR due to less immunological reactions/ side effects to the PNEUMOVAX 23. The outcome of the events and causality assessment were not provided. Additional information has been requested.
1. Pt. given nasal vaccine H1N1 per her request-D'cl from ordered injectable. 2. Varicella #2 given. Hx irregular menses, denied sexual activity, negative urine BHCG-10/09. Did not OK urine BHCG until end OV. Pt. changed her mind end of OV.
The pt suffered severe and permanent injuries including a seizure disorder, convulsions, encephalopathy, mental retardation, hypotonicity, coordination problems, ataxia, lethargy, developmental delay, physical and mental pain, suffering and emotional distress.
Mom stated that ER told her not to get HPV anymore since injection site had swelling, soreness and painful.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender,. No concurrent condition, medical history or allergy/drug reactions were reported. On 06-NOV-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K016966, expiry date: 10-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Arm pain, comes and goes, worse when using arm to lift anything. Sometimes very sore at rest. Hurts down arm from injection site all the way to thumb. No numbness, just aching.
Got fever and chills but then started vomiting non stop. Had to go to urgent care about 6 hours of vomiting and they gave me zofran and fluids and i felt better
My ankles and feet were extremely itchy; My ankles and feet have a rash; general achiness, that was gone by the morning 30Mar2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRURITUS (My ankles and feet were extremely itchy), RASH (My ankles and feet have a rash) and MYALGIA (general achiness, that was gone by the morning 30Mar2021) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), IRBESARTAN (AVAPRO) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced MYALGIA (general achiness, that was gone by the morning 30Mar2021). On 30-Mar-2021, the patient experienced PRURITUS (My ankles and feet were extremely itchy) and RASH (My ankles and feet have a rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash on leg and Itchy legs, at an unspecified dose and frequency. On 30-Mar-2021, MYALGIA (general achiness, that was gone by the morning 30Mar2021) had resolved. On 31-Mar-2021, PRURITUS (My ankles and feet were extremely itchy) had resolved. At the time of the report, RASH (My ankles and feet have a rash) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications included supplements.   This case was linked to MOD-2021-063849 (Patient Link).
Petechiae-like red dots on chest, neck and face. Appeared about 24 hours after dose and lasted for about 1 day. Also pain in arm that had injection, malaise and possible swollen glands in neck.
Found dead at home slumped on the floor; Loss of appetite; Body aches; Feverish; A spontaneous report was received from a physician, concerning a 65-years-old male patient, who received Moderna's COVID-19 Vaccine and experienced feverish, body aches, loss of appetite, and death.  The patient's medical history, as provided by the reporter, included diabetes, hypertension, Hashimoto's, smoker, cataracts, atrioventricular block, occasional premature ventricular contractions, and hypertriglyceridemia. Concomitant medications reported included metformin, glimepiride, lisinopril, atorvastatin, aspirin, methimazole, propranolol, and cilostazol.   On 05 Jan 2021, prior to the onset of events, the patient received the first of two planned doses of mRNA-1273 (lot number 037k20a) for COVID-19 infection prophylaxis.  On an unknown date in Jan 2021, some time after receiving the vaccine, the patient was feeling feverish with body aches and loss of appetite.  On 09 Jan 2021 at approximately 21:30, the patient was found dead at home slumped on the floor. According to the paramedics, the patient was dead longer than when his wife found him, and no resuscitation was performed.   Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of the events, feverish, body aches, loss of appetite, was considered resolved. The patient died on 09 Jan 2021. The cause of death was not reported.  The reporter assessed the event, death, as not related to Moderna's COVID-19 Vaccine. The reporter did not provide assessment for the events, feverish and body aches, in relation to Moderna's COVID-19 Vaccine.; Reporter's Comments: This case concerns a 65 year old male patient with medical history of diabetes, hypertension, Hashimoto's, smoker, cataracts, atrioventricular block, occasional premature ventricular contractions, and hypertriglyceridemia, who experienced the serious unexpected event of death, non-serious unexpected event of loss of appetite, and non-serious expected events of fever and body pain.  The event of death occurred 5 days after the first dose of mRNA-1273. The events of fever, body pain and loss of appetite occurred an unspecified period of time after the first dose of mRNA-1273.  Very limited information regarding these events has been provided at this time.  Based on temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Definitive causal association is confounded by age and medical history of diabetes, hypertension, Hashimoto's, smoker, cataracts, atrioventricular block, occasional premature ventricular contractions, and hypertriglyceridemia.
More than 42 days for administration of second dose; Wasn't feeling good; Fever; Chills; Body aches; This spontaneous case was reported by a pharmacist and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (More than 42 days for administration of second dose), MALAISE (Wasn't feeling good), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (More than 42 days for administration of second dose), MALAISE (Wasn't feeling good), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (More than 42 days for administration of second dose) had resolved and MALAISE (Wasn't feeling good), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported.  The treatment information was not provided.   Reporter did not allow further contact
5 days after receiving the vaccine  I developed a cough and then the next day was diagnosed with pneumonia at the ER.  I did not have a cough or congestion previous to the vaccine.   Today is Oct. 23 and I still have pneumonia.  I have taken 3 different antibiotics.
11OCT94 the rt arm pit began to swell-on 12OCT94 the armpit area became quite swollen, painful & hurt; no reddness or itching; pt seen by MD 13OCT94; the swelling subsided-recommended not recvd a flu shot next year;
Patient was given Yellow Fever vaccine on 07/20/2022 but a later search of his vaccine record showed that he had received the Yellow Fever vaccine on 03/3/2020. There are no symptoms being reported yet by the parents. However, wanted to be informed about what to do next if possible.
Redness around injection site 1-2 days later. Expanding & tx with ABX for cellulitis
High fever to 103 with myalgias followed by abdominal cramping and persistent  nausea and diarrhea through today 5/14/2021.
This spontaneous report as received from a healthcare worker via a company representative refers to 33 patients of unknown age and gender. On an unknown date the patients were vaccinated with (Merck) VARIVAX (dose, route and Lot # were not reported). No other co-suspects were reported. No concomitant medications were reported. It was reported that on an unknown date "greater than 2 weeks" ago, 56 patients had Chicken Pox due to vaccine failure. 23 patients had two doses of VARIVAX (MARRS case # 1211USA001898, Same reporter link). One of the 23 patients was reported to be pregnant (MARRS case # 1211USA001899, Same reporter link). There was no correlation between lot number, age or provider. No treatment information was reported. The outcome of vaccine failure and chicken pox is unknown. The relatedness for vaccine failure and chicken pox was not reported for (Merck) VARIVAX. Additional information has been requested.
Yeast infections; Bacterial vaginosis; This spontaneous case was reported by a consumer and describes the occurrence of FUNGAL INFECTION (Yeast infections) and BACTERIAL VAGINOSIS (Bacterial vaginosis) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Ankylosing spondylitis.    No Medical History information was reported.   In December 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced FUNGAL INFECTION (Yeast infections) and BACTERIAL VAGINOSIS (Bacterial vaginosis). At the time of the report, FUNGAL INFECTION (Yeast infections) and BACTERIAL VAGINOSIS (Bacterial vaginosis) was resolving.            Concomitant product use was not provided by the reporter.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  The causality for the events of yeast infections and bacterial vaginosis with Humira was provided as no reasonable possibility.  No treatment information was provided.   Reporter did not allow further contact
severe fatigue day of vaccine, next day 1/7 also headache and general feeling unwell and arm pain at site of injection. Fatigue and headache-stabbing pain R side of head continue. Head pain increased overnight 1/12.  Rash on forehead started 1/10 or 1/11, eye pain.  1/13 went to urgent care and diagnosed with  shingles.  Today rash continues,eye worse, severe pain on R side of head mostly in front of and around R ear into jaw and neck. Started on Valtrex
cough for 9 months with intermittent return. NEVER SMOKER, no previous pulmonary issues, allergy tests negative. failed PFTs. diagnosed with asthma at the age of 71.
pain on the left side of the hip; preventing her from walking; She said felt heavy; This is a spontaneous report from a contactable pharmacist. A 12-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified 2021 the patient experienced pain on the left side of the hip, preventing her from walking, she said felt heavy. The outcome of event was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
On the evening of February 24th after the I received the vaccine, I had severe pain on my left lower back radiating all the way to my left foot with tingling. I didn't sleep for 4 nights and I had difficulty walking. On February 28th I went to Emergency Room and I was given a Toradol shot. On Monday, March 1st I went to my primary doctor and gave Prednisone, Gabapentin and Meloxicam tablets then I was given 9 days off from work. Up to the present, I'm under physical therapy  and I still have on and off pain on my left leg.
Pt presents with right forearm rash, generalized itchiness, nausea, throat itch and feeling throat closing. Past med history: asthma managed with daily Benadryl, albuterol for rescue. Exam: generalized rash, diffuse redness around right forearm and left flank. lungs have bilateral wheezing. tachycardia.  9:23 IM epi given in right thigh 9:25 25mg Benadryl IM  9:30 nausea/vomiting resolved  9:40 pt taken to hospital for observation
pt recv vax; v; MD seen; ordered ATBs; supp fir n & inc T; 16apr sz & apnea; dx as pneumonia; CAT scan done;
FEVER, RUNNY NOSE, COUGHING, COLD SORE AND ARM SWOLLEN TO SIZE OF PINEAPPLE OR SOFTBALL.
six people with the same death; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "six people with the same death". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300173665 same reporter/drug/event, different patient;; Reported Cause(s) of Death: six people with the same death
Information has been received from a 60 year old female with scopolamine allergy and no pertinent medical history who on 13-DEC-2010 was vaccinated with ZOSTAVAX (Merck) (lot # not reported). Concomitant therapy included rizatriptan benzoate. On 14-DEC-2010 the patient had some swelling and warmth as well as some bruising and redness about the size of a baseball. The swelling, warmth, bruising and redness were located below the injection site, closer to the elbow. The patient received no treatment. The outcome of the events was not reported. No lab diagnostics studies performed. The patient did not seek medical attention. Follow up information has been received from the patient who reported that she received ZOSTAVAX (Merck) from a pharmacist. Her arm was swollen, hot and discolored. She returned to the pharmacist but the pharmacist was off till next day. By then (day 3) her arm was much better. The patient did not see her physician for the injection. The patient was fine at the time of this report. No further information is expected.
Around injection site, reddening, some areas raised. Itchy. About 4 inches across and 6 inches down.
Vaccine administered was not Age appropriate. Patient was notified (Parents) & Pt had no adverse reaction.
One hour after vaccination a rash was noted in the thighs, back, no fever, no problems breathing. About 4 hours later after mother called to report the rash. 8 hours later mother called the PCP and reported the rash is from "head to toe" patient was a little bit cranky, no problems breathing no fever, some decrease appetite. There was a big "welt" close to the side of the injections. She was asked to report to emergency room. Patient was given Prednisone and Benadryl one dose of each. Follow up phone call the following morning mother reported less rash and baby is back to normal. On examination today the baby looked well with faint macular few papular rash on the trunk, and cheek. There was about 1 ½ inch circular rash left thigh close to the site of injection and about and inch circular rash on the right thigh. She was prescribe hydroxyzine and Epipen.  And was referred to an allergist.
fingers started to hurt a lot, middle finger on the right hand and the fat fingers on both hands on the joints; wrist hurt; Lower back pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (fingers started to hurt a lot, middle finger on the right hand and the fat fingers on both hands on the joints), ARTHRALGIA (wrist hurt) and BACK PAIN (Lower back pain) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B121A and 019B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL and SIMVASTATIN for an unknown indication.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Jun-2021, the patient experienced BACK PAIN (Lower back pain). On an unknown date, the patient experienced PAIN IN EXTREMITY (fingers started to hurt a lot, middle finger on the right hand and the fat fingers on both hands on the joints) and ARTHRALGIA (wrist hurt). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (fingers started to hurt a lot, middle finger on the right hand and the fat fingers on both hands on the joints), ARTHRALGIA (wrist hurt) and BACK PAIN (Lower back pain) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.    For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Oral lesions; This is a spontaneous report from a contactable other healthcare professional (patient). A 69-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection lot Number: EN6198), intramuscular, administered in right arm on 20Feb2021 at 10:15 (age at the time of vaccination was 69 years) as single dose for COVID-19 immunisation. Other medical history included coronary artery disease from an unknown date and unknown if ongoing and Known allergies were reported as no. The patient's concomitant medications were not reported. If other vaccine in four weeks was reported as no and the patient did not have COVID prior vaccination. On 20Feb2021 at 19:15, the patient experienced oral lesions. AE treatment was reported as no and the patient was not tested for COVID post vaccination. The outcome of the event was not recovered.  Follow-up attempts completed. No further information expected.
Received Pfizer vaccines on 3/4/21, 3/25/21; tested positive for COVID-19 by PCR on 7/15/21, asymptomatic and tested due to known exposure.
This spontaneous report as received from a medical assistant refers to an unknown number of patients. On unspecified dates, an unknown number of patients were inadvertently administered GARDASIL (dose and route of administration were not provided) lot# K016966 exp. 10-MAY-2017, that had been improperly stored. No adverse effects reported. No PQC involved. Additional information has been requested.